Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | DVA | TMO |
|---|
| Close | 187.50 | 697.00 |
| Market Cap | $11.6B | $258B |
| 1M | +7.19% | +3.25% |
| P/E (TTM) | 13.5 | 36.4 |
| Forward P/E | 12.4 | 24.6 |
| P/E 5-Yr Percentile | 19 | 78 |
| P/S | 0.8 | 5.4 |
| P/B | 94.5 | 4.7 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $3.6B | $12.1B |
| Revenue YoY | +4.6% | +9.1% |
| Gross Margin | — | — |
| Latest Quarter EPS | 3.40 | 4.64 |
| Avg Post-Earnings Move | ±12.9% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 6.26% | 1.82% |
| 90-Day Net Insider Buying | — | −$40.3M |
DVA · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
